Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Journal of Pharmaceutical Sciences|February 3, 2015
Modeling the oxidation of methionine residues by peroxides in proteinsNaresh Chennamsetty, Yong Quan, Vishal Nashine, et al.The Journal of Chemical Physics|April 20, 2005
Cosurfactant and cosolvent effects on surfactant self-assembly in supercritical carbon dioxideNaresh Chennamsetty, Henry Bock, Lauriane F Scanu, et al.Journal of Pharmaceutical Sciences|January 27, 2011
Evaluation of a non-Arrhenius model for therapeutic monoclonal antibody aggregationVeysel Kayser, Naresh Chennamsetty, Vladimir Voynov, et al.Biotechnology and Bioengineering|January 13, 2022
Assessing detergent-mediated virus inactivation, protein stability, and impurity clearance in biologics downstream processesHasin Feroz, Naresh Chennamsetty, Sara Byers, et al.Biotechnology Journal|October 16, 2010
Glycosylation influences on the aggregation propensity of therapeutic monoclonal antibodiesVeysel Kayser, Naresh Chennamsetty, Vladimir Voynov, et al.Biotechnology Journal|September 29, 2011
A screening tool for therapeutic monoclonal antibodies: Identifying the most stable protein and its best formulation based on thioflavin T bindingVeysel Kayser, Naresh Chennamsetty, Vladimir Voynov, et al.Antibody Therapeutics|October 27, 2022
Role of harvest depth filtration in controlling product-related impurities for a bispecific antibodyEhsan Espah Borujeni, Weixin Jin, Chun Shao, et al.Analytical Chemistry|March 28, 2019
Quadrupole Dalton-Based Controlled Proteolysis Method for Characterization of Higher Order Protein StructureXiang Cao, Shannon C Flagg, Xue Li, et al.Bioconjugate Chemistry|January 23, 2010
Design and application of antibody cysteine variantsVladimir Voynov, Naresh Chennamsetty, Veysel Kayser, et al.Journal of Pharmaceutical Sciences|September 22, 2011
Developability index: a rapid in silico tool for the screening of antibody aggregation propensityTimothy M Lauer, Neeraj J Agrawal, Naresh Chennamsetty, et al.Pageof 4